These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 30158187)
1. Electrosprayed microparticles for intestinal delivery of prednisolone. Shams T; Illangakoon UE; Parhizkar M; Harker AH; Edirisinghe S; Orlu M; Edirisinghe M J R Soc Interface; 2018 Aug; 15(145):. PubMed ID: 30158187 [TBL] [Abstract][Full Text] [Related]
2. Engineering polymer blend microparticles: an investigation into the influence of polymer blend distribution and interaction. Alhnan MA; Basit AW Eur J Pharm Sci; 2011 Jan; 42(1-2):30-6. PubMed ID: 20950685 [TBL] [Abstract][Full Text] [Related]
3. A novel double-coating approach for improved pH-triggered delivery to the ileo-colonic region of the gastrointestinal tract. Liu F; Moreno P; Basit AW Eur J Pharm Biopharm; 2010 Feb; 74(2):311-5. PubMed ID: 19932177 [TBL] [Abstract][Full Text] [Related]
4. Extended release delivery system of metoprolol succinate using hot-melt extrusion: effect of release modifier on methacrylic acid copolymer. Sawant KP; Fule R; Maniruzzaman M; Amin PD Drug Deliv Transl Res; 2018 Dec; 8(6):1679-1693. PubMed ID: 29948916 [TBL] [Abstract][Full Text] [Related]
5. A pH-dependent colon targeted oral drug delivery system using methacrylic acid copolymers. I. Manipulation Of drug release using Eudragit L100-55 and Eudragit S100 combinations. Khan MZ; Prebeg Z; Kurjaković N J Control Release; 1999 Mar; 58(2):215-22. PubMed ID: 10053194 [TBL] [Abstract][Full Text] [Related]
6. Influence of lidocaine forms (salt vs. freebase) on properties of drug-eudragit® L100-55 extrudates prepared by reactive melt extrusion. Liu X; Ma X; Kun E; Guo X; Yu Z; Zhang F Int J Pharm; 2018 Aug; 547(1-2):291-302. PubMed ID: 29883791 [TBL] [Abstract][Full Text] [Related]
7. Development of enteric-coated fixed dose combinations of amorphous solid dispersions of ezetimibe and lovastatin: Investigation of formulation and process parameters. Riekes MK; Dereymaker A; Berben P; Augustijns P; Stulzer HK; Van den Mooter G Int J Pharm; 2017 Mar; 520(1-2):49-58. PubMed ID: 28153650 [TBL] [Abstract][Full Text] [Related]
8. Mucoadhesive platforms for targeted delivery to the colon. Varum FJ; Veiga F; Sousa JS; Basit AW Int J Pharm; 2011 Nov; 420(1):11-9. PubMed ID: 21856393 [TBL] [Abstract][Full Text] [Related]
9. Fabrication and in vivo evaluation of highly pH-responsive acrylic microparticles for targeted gastrointestinal delivery. Kendall RA; Alhnan MA; Nilkumhang S; Murdan S; Basit AW Eur J Pharm Sci; 2009 Jun; 37(3-4):284-90. PubMed ID: 19491017 [TBL] [Abstract][Full Text] [Related]
10. Comparison of simple Eudragit microparticles loaded with prednisolone and Eudragit-coated chitosan-succinyl-prednisolone conjugate microparticles: Part I. Particle characteristics and in vitro evaluation as a colonic delivery system. Onishi H; Kikuchi H; Machida Y Drug Dev Ind Pharm; 2012 Jul; 38(7):800-7. PubMed ID: 22077373 [TBL] [Abstract][Full Text] [Related]
11. Preparation and in vitro release of zein microparticles loaded with prednisolone for oral delivery. Lau ET; Johnson SK; Mikkelsen D; Halley PJ; Steadman KJ J Microencapsul; 2012; 29(7):706-12. PubMed ID: 22612552 [TBL] [Abstract][Full Text] [Related]
12. Eudragit RS 100 microparticles containing 2-hydroxypropyl-beta-cyclodextrin and glutathione: physicochemical characterization, drug release and transport studies. Trapani A; Laquintana V; Denora N; Lopedota A; Cutrignelli A; Franco M; Trapani G; Liso G Eur J Pharm Sci; 2007 Jan; 30(1):64-74. PubMed ID: 17118631 [TBL] [Abstract][Full Text] [Related]
13. Studies of chitosan/organic acid/Eudragit RS/RL-coated system for colonic delivery. Kaur K; Kim K Int J Pharm; 2009 Jan; 366(1-2):140-8. PubMed ID: 18835342 [TBL] [Abstract][Full Text] [Related]
14. Spray-dried Eudragit® L100 microparticles containing ferulic acid: Formulation, in vitro cytoprotection and in vivo anti-platelet effect. Nadal JM; Gomes MLS; Borsato DM; Almeida MA; Barboza FM; Zawadzki SF; Kanunfre CC; Farago PV; Zanin SMW Mater Sci Eng C Mater Biol Appl; 2016 Jul; 64():318-328. PubMed ID: 27127059 [TBL] [Abstract][Full Text] [Related]
15. Comparative evaluation of interpolyelectrolyte complexes of chitosan with Eudragit L100 and Eudragit L100-55 as potential carriers for oral controlled drug delivery. Moustafine RI; Margulis EB; Sibgatullina LF; Kemenova VA; Van den Mooter G Eur J Pharm Biopharm; 2008 Sep; 70(1):215-25. PubMed ID: 18691856 [TBL] [Abstract][Full Text] [Related]
16. Colonic delivery of indometacin loaded PGA-co-PDL microparticles coated with Eudragit L100-55 from fast disintegrating tablets. Tawfeek HM; Abdellatif AAH; Dennison TJ; Mohammed AR; Sadiq Y; Saleem IY Int J Pharm; 2017 Oct; 531(1):80-89. PubMed ID: 28818458 [TBL] [Abstract][Full Text] [Related]
18. Morphological and physicochemical evaluation of the propranolol HCl-Eudragit Garjani A; Barzegar-Jalali M; Osouli-Bostanabad K; Ranjbar H; Adibkia K Artif Cells Nanomed Biotechnol; 2018 Jun; 46(4):749-756. PubMed ID: 28587486 [TBL] [Abstract][Full Text] [Related]
19. Preparation of microparticles of naproxen with Eudragit RS and talc by spherical crystallization technique. Maghsoodi M; Esfahani M Pharm Dev Technol; 2009; 14(4):442-50. PubMed ID: 19235551 [TBL] [Abstract][Full Text] [Related]
20. Statistical optimization of indomethacin pellets coated with pH-dependent methacrylic polymers for possible colonic drug delivery. Akhgari A; Afrasiabi Garekani H; Sadeghi F; Azimaie M Int J Pharm; 2005 Nov; 305(1-2):22-30. PubMed ID: 16236475 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]